Evotec has received a US$5m milestone payment from Bristol Myers Squibb following the US Food and Drug Administration’s ...
Adocia has announced the filing of a patent for its new long-acting peptide platform, AdoXLong, aimed at improving treatment options for diabetes and obesity. The French biopharmaceutical company said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback